Description
GLYPIN Tablets 2 mg – 28’s
GLYPIN 2 mg Tablets contain Vildagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus. Vildagliptin works by enhancing the levels of incretin hormones, which increases insulin secretion and decreases glucagon release in a glucose-dependent manner—helping to regulate blood sugar levels more effectively, especially after meals.
GLYPIN is suitable for monotherapy in patients who are intolerant to Metformin or as part of combination therapy with other antidiabetic agents such as Metformin, sulfonylureas, or insulin. It offers good glycemic control with a low risk of hypoglycemia and is generally weight neutral, making it a preferred option for long-term diabetes management.
Each pack contains 28 tablets, offering a convenient four-week supply based on standard once-daily dosing.
Key Features:
-
Contains 2 mg Vildagliptin per tablet
-
DPP-4 inhibitor for type 2 diabetes management
-
Enhances insulin secretion and suppresses glucagon
-
Suitable as monotherapy or in combination therapy
-
Low risk of hypoglycemia and weight neutral
-
Pack of 28 tablets for a 4-week treatment course
Usage:
Use exactly as prescribed by your physician. Regular monitoring of blood glucose levels is advised.
Reviews
There are no reviews yet.